Forward Citations = 2

Loading Chart...

3 inventors (with patents filed for the assignee):

Alberto Reiner (2 out of 34 patents)

Carlo Scolastico (2 out of 20 patents)

Giovanni Tronconi (2 out of 3 patents)

4 patents: Sort by Forward Citations

1. 4824978 - Complexes of glycerylphosphorylcholine (1989-04-25),

2. 4699901 - Diacyl derivatives of glycerylphosphorylcholine, their preparation, and (1987-10-13),

3. 4471115 - Water soluble derivatives of cephalex and process for their preparation (1984-09-11),

4. 4268685 - Salicylamide esters and related pharmaceutical composition (1981-05-19),

Company Overview

Neopharmed S.p.a. is a leading pharmaceutical company in Italy, committed to improving people's health and well-being. With a focus on innovation and research, Neopharmed develops and distributes high-quality pharmaceutical products across various therapeutic areas. The company's mission is to provide patients with safe and effective treatments to enhance their quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#346 in Milan

#1,960 in Italy

Milan, Italy

Neopharmed S.p.a.

Forward Citations = 2

3 inventors:

Alberto Reiner (2 out of 34 patents)

Carlo Scolastico (2 out of 20 patents)

Giovanni Tronconi (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neopharmed S.p.a.. Retrieved from https://idiyas.com/company/neopharmed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]